Department of Psychiatry, University of Oxford, United Kingdom. denis.o'
J Affect Disord. 2010 Sep;125(1-3):221-6. doi: 10.1016/j.jad.2010.02.107. Epub 2010 Mar 19.
This paper extends previous work describing course in depression using a recommended operational model that defines remission onset and relapse. We test whether a similar course pattern would emerge using this model in a new cohort of depressed participants.
We recruited a cohort of 86 participants, first-time inpatients, with DSM-IV major depression. Outcome was assessed prospectively over a 13-month minimum follow-up period. Remission onset was defined as a Ham-D score <8 for two consecutive weeks; relapse as a Ham-D score >16 for two consecutive weeks and meeting DSM-IV criteria for major depressive disorder.
The cumulative probability of remission onset was 0.62 (SE=0.05) and 0.80 (SE=0.05) at 3 and 6 months following study entry. The relapse risk was 0.28 (SE=0.05) at 6 months post remission onset; 53% of those relapsing did so in the first 2 months post remission onset. Predictors of longer times to remission onset included: longer illness length, higher anxiety scores and unemployment; higher anxiety scores predicted relapse. The course pattern is similar to that reported previously.
These findings apply to inpatients only. Course was not rated blind to all of the participants' baseline data.
Defining remission onset and relapse using this model is associated with a replicable course pattern. A singular clinical advantage of the model is the identification of those participants at highest risk of relapse 2 months post remission onset.
本文扩展了先前使用推荐的操作模型描述抑郁症病程的工作,该模型定义了缓解开始和复发。我们使用该模型在一组新的抑郁患者中测试是否会出现类似的病程模式。
我们招募了一组 86 名首次住院的 DSM-IV 重性抑郁患者作为队列。结果在至少 13 个月的随访期内进行前瞻性评估。缓解开始定义为连续两周汉密尔顿抑郁量表(Ham-D)评分<8;复发定义为连续两周 Ham-D 评分>16 且符合 DSM-IV 重性抑郁障碍标准。
研究入组后 3 个月和 6 个月时,缓解开始的累积概率分别为 0.62(SE=0.05)和 0.80(SE=0.05)。缓解开始后 6 个月的复发风险为 0.28(SE=0.05);53%的复发患者在缓解开始后 2 个月内复发。缓解开始时间延长的预测因素包括:病程较长、焦虑评分较高和失业;焦虑评分较高预测复发。病程模式与先前报道的相似。
这些发现仅适用于住院患者。病程评估未对所有参与者的基线数据进行盲法评估。
使用该模型定义缓解开始和复发与可复制的病程模式相关。该模型的一个独特临床优势是能够识别出缓解开始后 2 个月复发风险最高的患者。